Seth Klarman
Baupost Group
Seth Klarman TOBIRA THERAPEUTICS INC stake
total: 272
Baupost Group TBRA trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2016 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q4
According to 2026 Q2 report, Seth Klarman doesn't hold any TOBIRA THERAPEUTICS INC (TBRA) shares. To date, the estimated cost basis is nearly $39.74 for "buy" trades and estimated average "sell" price is $39.74. Baupost Group first purchased TBRA in 2016 Q3, initially acquiring 160,829 shares. Since the initial investment in TOBIRA THERAPEUTICS INC (TBRA), Baupost Group has made 1 more transaction.
When did Seth Klarman sell TOBIRA THERAPEUTICS INC (TBRA)?
Seth Klarman sold off the entire TOBIRA THERAPEUTICS INC (TBRA) position in 2016 Q4.
When did Seth Klarman buy TOBIRA THERAPEUTICS INC (TBRA)?
Seth Klarman first invested in TOBIRA THERAPEUTICS INC (TBRA) in 2016 Q3 at the reported quarter-end price of $39.74 per share.
What's the cost basis of Baupost Group's TBRA stake?
The estimated cost basis for TOBIRA THERAPEUTICS INC (TBRA) stake is around $39.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $39.74
- Weighted AVG sell price:
- $39.74
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.